Bangladesh's Incepta sells Hep C drug copy abroad; Marken opens Shanghai office;

> Bangladesh's Incepta plans to sell hepatitis drug copy abroad. Story

> FTC passed a final regulatory order for the Sun-Ranbaxy merger. Story

> Yew Biopharma inks sales agreement with Heilongjiang province. Release

> Marken opens office in Shanghai aimed at logistics. Release

> U.K.-based Ergomed expands to Taiwan to offer clinical services. Release